| Typicality: | 0.427 |
| Saliency: | 0.416 |
| in veins | 5 | location |
| in patients with atrial fibrillation | 5 | other |
| to prevent strokes | 4 | purpose |
| drug → prevent → blood clots | 42 |
| drug → be used to prevent → blood clots | 16 |
| drug → be designed to prevent → blood clots | 6 |
| drug → help prevent → blood clots | 4 |
| negative | neutral | positive |
| 0.281 | 0.618 | 0.101 |
| Raw frequency | 68 |
| Normalized frequency | 0.416 |
| Modifier score | 0.500 |
| Perplexity | 36.598 |